Sector pending / Biological Products, Except Diagnostic SubstancesUpdated 2026-05-10 22:07 UTC

FRA/XP0 stock hub

FRA/XP0 has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

FRA/XP0is not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

4.6B

Frankfurt Stock Exchange

Market data

Live price

Current market quote for this ticker.

Current price

FRA/XP0

In the news

Latest news · FRA/XP0

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/En/a

P25 n/aP50 n/aP75 n/a

Trailing P/En/a

P25 n/aP50 n/aP75 n/a

ROE-37.5

P25 n/aP50 n/aP75 n/a

ROIC-25.1

P25 n/aP50 n/aP75 n/a

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All FRA/XP0 market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

148

Groups with data

Currency

USD

Showing 148 of 148 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	Canada
Country code	DE
Employees	364
Employees Change	43%
Employees Change Percent	13.15
Enterprise value	EUR 3.5B
Exchange	Frankfurt Stock Exchange
Financial currency	USD
First seen	2026-05-10
Industry	Biological Products, Except Diagnostic Substances
Last refreshed	2026-05-10
Market cap	EUR 4.6B
Price	EUR 48.4
Price currency	EUR
Sic	2836
Symbol	fra/XP0
Website	https://www.xenon-pharma.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	-7.17%
EV Earnings	-10.52x
EV/FCF	-13.12x
FCF yield	-5.75%
P/B ratio	3.99x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
Gross Profit	EUR -284.7M
Net Income	EUR -332.3M
Profit Per Employee	EUR -912,964
ROA	-24.22
Roa5y	-18.62
ROCE	-30.64
ROE	-37.53
Roe5y	-28.66
ROIC	-25.07

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr10y	24%
Cagr1y	55.18%
Cagr3y	8.78%
Cagr5y	26.57%

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Assets	EUR 1.2B
Cash	EUR 949.5M
Current Assets	EUR 938.4M
Current Liabilities	EUR 33.8M
Debt	EUR 6.5M
Debt Equity	EUR 0.01
Debt FCF	EUR -0.02
Equity	EUR 1.2B
Liabilities	EUR 42.5M
Long Term Assets	EUR 264.4M
Long Term Liabilities	EUR 8.7M
Net Cash	EUR 1.2B
Net Cash By Market Cap	EUR 24.93
Net Cash Growth	95.2%
Net Debt Equity	EUR -1
Tangible Book Value	EUR 1.2B
Tangible Book Value Per Share	EUR 12.01

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	27.79
Net Working Capital	EUR -22.9M
Quick ratio	27.53
Working Capital	EUR 925.3M

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-4.16%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
10Y total return	758.92%
1Y total return	55.13%
200-day SMA	37.07
3Y total return	28.72%
50-day SMA	46.54
50-day SMA vs 200-day SMA	50over200
5Y total return	224.83%
All Time High	53.5
All Time High Change	-9.53%
All Time High Date	2026-03-10
All Time Low	1.81
All Time Low Change	2,581.44%
All Time Low Date	2017-11-15
ATR	0.91
Ch YTD	29.41
High	48.4
High52	53.5
High52 Date	2026-03-10
High52ch	-9.53%
Low	47.6
Low52	25
Low52 Date	2025-06-02
Low52ch	93.6%
Ma50ch	4%
Price vs 200-day SMA	30.56%
RSI	52.87
RSI Monthly	64.53
RSI Weekly	66.12
Sharpe ratio	1.01x
Sortino ratio	2.15
Total Return	-4.16%
Tr YTD	29.41
Tr1m	-1.22%
Tr1w	1.68%
Tr3m	42.35%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	EUR -357.9M

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	91,105,169%
Shares Insiders	0.12%
Shares Institutions	83.02%
Shares Qo Q	9.01%
Shares Yo Y	4.16%
Short Ratio	3.45

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	EUR -317.2M
Average Volume	52.1x
Bv Per Share	12.01
CAPEX	EUR -771,030
Ch10y	758.9
Ch1m	-1.22
Ch1w	1.68
Ch1y	55.13
Ch3m	42.35
Ch3y	28.72
Ch5y	224.8
Ch6m	47.56
Change	-3.2%
Change From Open	1.68
Close	50
Days Gap	-4.8
Depreciation Amortization	2,095,314.1
Dollar Volume	96.8
Earnings Date	2026-05-07
EBIT	EUR -357.9M
EBITDA	EUR -355.8M
EPS	EUR -4.08
F Score	2
FCF	EUR -266.5M
FCF EV Yield	-7.62x
Financing CF	831,719,018
Fiscal Year End	December
Founded	1,996
Income Tax	EUR -1.7M
Investing CF	-194,096,536
Is Primary Listing	0
Last Earnings Date	2026-05-07
Last Report Date	2026-03-31
Ma150	39.19
Ma150ch	23.5%
Ma20	48.56
Ma20ch	-0.32%
Net CF	372,253,833
Next Earnings Date	2026-08-07
Open	47.6
Position In Range	100
Ppne	12,364,981.9
Price Date	2026-05-08
Ptbv Ratio	3.99
Relative Volume	0.04x
Share Based Comp	50,673,737
Tr6m	47.56%
Volume	2
Z Score	36.19

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

Does FRA/XP0 pay a dividend?

Capital-return profile for this ticker.

Performance

FRA/XP0 stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns FRA/XP0?

Insider, institutional, and short-interest positioning.

Institutional ownership

+83.0%

Share of float held by funds and institutions

Insider ownership

+0.1%

Stake held by company insiders. Higher generally signals alignment.

Negative means the company is buying back shares.

Technical

FRA/XP0 momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

52.9

Neutral momentum band

Price vs 200-day MA

+30.6%

50/200-day relationship not available

Beta (5Y)

n/a

Sensitivity to the broader market

Sharpe ratio

1.00

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About FRA/XP0

Hub-level FAQ points readers to the deeper analysis pages.

What is the current fra/XP0 stock rating?

fra/XP0 is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full fra/XP0 analysis?

The full report lives at /stocks/fra/XP0/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for fra/XP0?

The latest report frames fra/XP0 around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the fra/XP0 page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.